A pattern of reduced activity in tumor-specific plasma B cells, evidenced by a universal downregulation of pathways involved in cell growth (Myc targets, mTOR pathway) and inflammation (interferon alpha/gamma, IL2, and TNF alpha signaling), may suggest a reduced function of plasma cells in the tumors. Here, MYC is linked to neoplasm.